StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
WGS

GeneDx Holdings Corp.

WGS Nasdaq Services-Health Services EDGAR ↗
$67.86
-1.10 -1.60%

Key statistics

from XBRL data in SEC filings
Market cap
$2.02B
Revenue (TTM)
$454M
Net income (TTM)
-$106M
EPS (TTM)
$-3.62
P/E ratio
Dividend yield
Free cash flow
$14.3M
Cash
$60.3M
Total assets
$481M
Gross margin
69.4%
52-week range
$32.21 – $170.87

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Shareholder vote results Jun 23, 2026 8-K Director or officer change; Regulation FD disclosure Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) May 4, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 23, 2026 8-K Results of operations (earnings release) Feb 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Oct 28, 2025 8-K Results of operations (earnings release) Oct 28, 2025 8-K Director or officer change Sep 18, 2025 10-Q Quarter ended 2025-06-30 Jul 29, 2025 8-K Results of operations (earnings release) Jul 29, 2025 8-K Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Results of operations (earnings release) Apr 30, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025 8-K Results of operations (earnings release) Feb 18, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Director or officer change; Regulation FD disclosure Jan 2, 2025 10-Q Quarter ended 2024-09-30 Oct 29, 2024 8-K Results of operations (earnings release) Oct 29, 2024 10-Q Quarter ended 2024-06-30 Jul 30, 2024 8-K Results of operations (earnings release) Jul 30, 2024 8-K Shareholder vote results Jun 24, 2024 8-K Entered a material agreement Apr 29, 2024 10-Q Quarter ended 2024-03-31 Apr 29, 2024 8-K Results of operations (earnings release) Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 23, 2024 8-K Results of operations (earnings release) Feb 20, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 3, 2023 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity Oct 30, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Results of operations (earnings release) Aug 8, 2023 8-K Director or officer change Jul 24, 2023 8-K Shareholder vote results Jun 20, 2023